Annual Total Long Term Liabilities
$491.26 M
+$11.69 M+2.44%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual total long term liabilities is $491.26 million, with the most recent change of +$11.69 million (+2.44%) on December 31, 2023.
- During the last 3 years, CHRS annual total long term liabilities has risen by +$76.24 million (+18.37%).
- CHRS annual total long term liabilities is now at all-time high.
Performance
CHRS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$297.41 M
+$1.45 M+0.49%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly total long term liabilities is $297.41 million, with the most recent change of +$1.45 million (+0.49%) on September 30, 2024.
- Over the past year, CHRS quarterly long term liabilities has dropped by -$180.32 million (-37.74%).
- CHRS quarterly long term liabilities is now -39.46% below its all-time high of $491.26 million, reached on December 31, 2023.
Performance
CHRS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CHRS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.4% | -37.7% |
| 3 y3 years | +18.4% | -37.4% |
| 5 y5 years | +368.8% | -37.4% |
CHRS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.0% | -39.5% | +0.5% |
| 5 y | 5-year | at high | +160.3% | -39.5% | +57.6% |
| alltime | all time | at high | +7969.3% | -39.5% | +723.2% |
Coherus BioSciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $297.41 M(+0.5%) |
| Jun 2024 | - | $295.96 M(-3.6%) |
| Mar 2024 | - | $307.09 M(-37.5%) |
| Dec 2023 | $491.26 M(+2.4%) | $491.26 M(+2.8%) |
| Sep 2023 | - | $477.72 M(+0.6%) |
| Jun 2023 | - | $474.92 M(-0.1%) |
| Mar 2023 | - | $475.53 M(-0.8%) |
| Dec 2022 | $479.57 M(+15.2%) | $479.57 M(+0.6%) |
| Sep 2022 | - | $476.72 M(+11.4%) |
| Jun 2022 | - | $427.88 M(+0.2%) |
| Mar 2022 | - | $427.08 M(+2.6%) |
| Dec 2021 | $416.28 M(+0.3%) | $416.28 M(+43.2%) |
| Sep 2021 | - | $290.62 M(-1.9%) |
| Jun 2021 | - | $296.27 M(-3.8%) |
| Mar 2021 | - | $308.03 M(-25.8%) |
| Dec 2020 | $415.02 M(+119.9%) | $415.02 M(+0.1%) |
| Sep 2020 | - | $414.57 M(+0.3%) |
| Jun 2020 | - | $413.47 M(+117.3%) |
| Mar 2020 | - | $190.25 M(+0.8%) |
| Dec 2019 | $188.74 M | $188.74 M(+0.0%) |
| Sep 2019 | - | $188.66 M(+3.0%) |
| Jun 2019 | - | $183.22 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $183.22 M(+74.8%) |
| Dec 2018 | $104.80 M(+1.1%) | $104.80 M(+0.3%) |
| Sep 2018 | - | $104.53 M(+0.2%) |
| Jun 2018 | - | $104.28 M(+0.3%) |
| Mar 2018 | - | $103.93 M(+0.2%) |
| Dec 2017 | $103.68 M(+0.9%) | $103.68 M(+0.3%) |
| Sep 2017 | - | $103.42 M(-1.9%) |
| Jun 2017 | - | $105.45 M(+2.1%) |
| Mar 2017 | - | $103.24 M(+0.5%) |
| Dec 2016 | $102.75 M(-9.3%) | $102.75 M(+0.5%) |
| Sep 2016 | - | $102.25 M(-50.1%) |
| Jun 2016 | - | $204.76 M(+2.3%) |
| Mar 2016 | - | $200.19 M(+76.7%) |
| Dec 2015 | $113.30 M(+65.0%) | $113.30 M(+42.1%) |
| Sep 2015 | - | $79.75 M(-4.2%) |
| Jun 2015 | - | $83.23 M(+31.6%) |
| Mar 2015 | - | $63.25 M(-7.9%) |
| Dec 2014 | $68.68 M(+90.1%) | $68.68 M(-4.5%) |
| Sep 2014 | - | $71.93 M(+14.1%) |
| Jun 2014 | - | $63.04 M(+74.5%) |
| Dec 2013 | $36.13 M(+493.4%) | $36.13 M |
| Dec 2012 | $6.09 M | - |
FAQ
- What is Coherus BioSciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Coherus BioSciences?
- What is Coherus BioSciences annual total long term liabilities year-on-year change?
- What is Coherus BioSciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Coherus BioSciences?
- What is Coherus BioSciences quarterly long term liabilities year-on-year change?
What is Coherus BioSciences annual total long term liabilities?
The current annual total long term liabilities of CHRS is $491.26 M
What is the all time high annual total long term liabilities for Coherus BioSciences?
Coherus BioSciences all-time high annual total long term liabilities is $491.26 M
What is Coherus BioSciences annual total long term liabilities year-on-year change?
Over the past year, CHRS annual total long term liabilities has changed by +$11.69 M (+2.44%)
What is Coherus BioSciences quarterly total long term liabilities?
The current quarterly long term liabilities of CHRS is $297.41 M
What is the all time high quarterly long term liabilities for Coherus BioSciences?
Coherus BioSciences all-time high quarterly total long term liabilities is $491.26 M
What is Coherus BioSciences quarterly long term liabilities year-on-year change?
Over the past year, CHRS quarterly total long term liabilities has changed by -$180.32 M (-37.74%)